Ensemble Modeling for Aromatic Production in Escherichia coli

por Rizk, Matthew L., Liao, James C.
Publicado 2009

Population Pharmacokinetic Analysis for Imipenem–Relebactam in Healthy Volunteers and Patients With Bacterial Infections

por Bhagunde, Pratik, Patel, Parul, Lala, Mallika, Watson, Kenny, Copalu, William, Xu, Ming, Kulkarni, Pooja, Young, Katherine, Rizk, Matthew L.
Publicado 2019

Understanding effect site pharmacology of uprifosbuvir, a hepatitis C virus nucleoside inhibitor: Case study of a multidisciplinary modeling approach in drug development

por van den Berg, Paul, Gao, Wei, Ahsman, Maurice J., Arrington, Leticia, Kesisoglou, Filippos, Miller, Randy, Post, Teun M., Rizk, Matthew L.
Publicado 2021

Population pharmacokinetic/pharmacodynamic assessment of imipenem/cilastatin/relebactam in patients with hospital‐acquired/ventilator‐associated bacterial pneumonia

por Patel, Munjal, Bellanti, Francesco, Daryani, Naveen M., Noormohamed, Nadia, Hilbert, David W., Young, Katherine, Kulkarni, Pooja, Copalu, William, Gheyas, Ferdous, Rizk, Matthew L.
Publicado 2021

Perspective on the State of Pharmacometrics and Systems Pharmacology Integration

por Trame, Mirjam N., Riggs, Matthew, Biliouris, Konstantinos, Marathe, Dhananjay, Mettetal, Jerome, Post, Teun M., Rizk, Matthew L., Visser, Sandra A. G., Musante, Cynthia J.
Publicado 2018

Validation of a Model Predicting Anti-infective Lung Penetration in the Epithelial Lining Fluid of Humans

por Aulin, Linda B. S., Valitalo, Pyry A., Rizk, Matthew L., Visser, Sandra A. G., Rao, Gauri, van der Graaf, Piet H., van Hasselt, J. G. Coen
Publicado 2018

Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects

por Rizk, Matthew L., Rhee, Elizabeth G., Jumes, Patricia A., Gotfried, Mark H., Zhao, Tian, Mangin, Eric, Bi, Sheng, Chavez-Eng, Cynthia M., Zhang, Zufei, Butterton, Joan R.
Publicado 2018

Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among patients wi...

por Roberts, Jason A, Nicolau, David P, Martin-Loeches, Ignacio, Deryke, C Andrew, Losada, Maria C, Du, Jiejun, Patel, Munjal, Rizk, Matthew L, Paschke, Amanda, Chen, Luke F
Publicado 2023

In Vitro Hollow-Fiber Studies Assessing Antibacterial Activity of Ceftolozane/Tazobactam Against Multidrug-Resistant Pseudomonas Aeruginosa

por Carr, Donna, Zhang, Zufei, Si, Qian, Racine, Fred, Xiao, Jing Chen, Katwaru, Ravi, Wismer, Michael K, Johnson, Matthew G, Feng, Hwa-Ping, Young, Katherine, Rizk, Matthew L, Motyl, Mary
Publicado 2020

Population Pharmacokinetics, Exposure-Response, and Probability of Target Attainment Analyses for Tedizolid in Adolescent Patients with Acute Bacterial Skin and Skin Structure Infe...

por Li, Dan, Sabato, Philip E., Guiastrennec, Benjamin, Ouerdani, Aziz, Feng, Hwa-Ping, Duval, Vincent, De Anda, Carisa S., Sears, Pamela S., Chou, Margaret Z., Hardalo, Catherine, Broyde, Natalya, Rizk, Matthew L.
Publicado 2021

Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants

por Rhee, Elizabeth G., Rizk, Matthew L., Calder, Nicole, Nefliu, Marcela, Warrington, Steven J., Schwartz, Michael S., Mangin, Eric, Boundy, Keith, Bhagunde, Pratik, Colon-Gonzalez, Francheska, Jumes, Patricia, Liu, Yang, Butterton, Joan R.
Publicado 2018

A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ven...

por Titov, Ivan, Wunderink, Richard G, Roquilly, Antoine, Rodríguez Gonzalez, Daniel, David-Wang, Aileen, Boucher, Helen W, Kaye, Keith S, Losada, Maria C, Du, Jiejun, Tipping, Robert, Rizk, Matthew L, Patel, Munjal, Brown, Michelle L, Young, Katherine, Kartsonis, Nicholas A, Butterton, Joan R, Paschke, Amanda, Chen, Luke F
Publicado 2020